Machine Learning in Precision Oncology: Integrating Multimodal Clinical Data for Treatment Selection
Journal of Precision Medicine and Artificial Intelligence · 09.06.2026
DOI: 10.64949/3dfqcq13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Precision Medicine and Artificial Intelligence, online erschienen am 09.06.2026. Verfasst von Simbarashe Magwenzi. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This article is a preprint and has not yet been peer-reviewed. Not for clinical use. Integration of complex molecular, pathological, radiological, and longitudinal clinical data to guide treatment selection is becoming increasingly important for precision oncology. However, the volume and heterogeneity of these data often exceed the capacity of conventional clinical workflows and traditional statistical approaches. Machine learning, particularly deep learning, offers a computational framework for identifying non-linear patterns across high-dimensional datasets and generating clinically relevant predictions. This review summarises current and emerging applications of machine learning in precision oncology, with emphasis on multimodal data integration for biomarker discovery, patient stratification, treatment-response prediction, toxicity monitoring, and molecular tumour board support. Key examples include prediction of microsatellite instability from routine histology, integration of radiology, pathology, and genomic features to predict response to immune checkpoint inhibitors, multi-omic prediction of neoadjuvant chemotherapy response in breast cancer, and radiogenomic approaches for non-invasive assessment of tumour heterogeneity. Despite promising retrospective performance, many models remain investigational and require prospective, multi-centre validation before routine clinical implementation. Established reporting and evaluation frameworks, including TRIPOD+AI, DECIDE-AI, CONSORT-AI, SPIRIT-AI, and CLAIM, provide important guidance for translating machine-learning models from research settings into safe and effective clinical decision support. The central challenge is not whether machine learning can generate accurate predictions, but whether these predictions improve decisions that matter to patients.
Zitieren
APA
Magwenzi, S. (2026). Machine Learning in Precision Oncology: Integrating Multimodal Clinical Data for Treatment Selection. Journal of Precision Medicine and Artificial Intelligence. https://doi.org/10.64949/3dfqcq13
Vancouver
Magwenzi S. Machine Learning in Precision Oncology: Integrating Multimodal Clinical Data for Treatment Selection. Journal of Precision Medicine and Artificial Intelligence. 2026. doi:10.64949/3dfqcq13
BibTeX
@article{Magwenzi2026,
author = {Magwenzi, Simbarashe},
title = {Machine Learning in Precision Oncology: Integrating Multimodal Clinical Data for Treatment Selection},
journal = {Journal of Precision Medicine and Artificial Intelligence},
year = {2026},
doi = {10.64949/3dfqcq13}
}
EUVIMED